Related references
Note: Only part of the references are listed.The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
H. -D. Wu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis
Holli A. Loomans-Kropp et al.
CANCER PREVENTION RESEARCH (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Do proton pump inhibitors prevent Barrett's esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis
Yue Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Metformin Use and the Risk of Cancer in Patients with Diabetes: A Nationwide Sample Cohort Study
Tak Kyu Oh et al.
CANCER PREVENTION RESEARCH (2020)
Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study
Qiao-Li Wang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study
Shuai Yuan et al.
DIABETES (2020)
Use of metformin and aspirin is associated with delayed cancer incidence
Joseph J. Y. Sung et al.
CANCER EPIDEMIOLOGY (2020)
Metformin Inhibit Lung Cancer Cell Growth and Invasion in Vitro as Well as Tumor Formation in Vivo Partially by Activating PP2A
Xiaohu Zhou et al.
MEDICAL SCIENCE MONITOR (2019)
Metformin inhibited colitis and colitis-associated cancer (CAC) through protecting mitochondrial structures of colorectal epithelial cells in mice
Shu-Qing Wang et al.
CANCER BIOLOGY & THERAPY (2019)
Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer
Harvey J. Murff et al.
CANCER CAUSES & CONTROL (2018)
Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma
Tom Thomas et al.
JOURNAL OF GASTROINTESTINAL CANCER (2018)
Metformin: historical overview
Clifford J. Bailey
DIABETOLOGIA (2017)
Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
Chin-Hsiao Tseng
Oncotarget (2016)
Meta-analysis in clinical trials revisited
Rebecca DerSimonian et al.
CONTEMPORARY CLINICAL TRIALS (2015)
Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
Y. Feng et al.
CELL DEATH & DISEASE (2014)
LKB1 and AMPK and the cancer-metabolism link - ten years after
D. Grahame Hardie et al.
BMC BIOLOGY (2013)
Antitumor effect of metformin in esophageal cancer: In vitro study
Mitsuyoshi Kobayashi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives Results from a large population-based follow-up study
Rikje Ruiter et al.
DIABETES CARE (2012)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
A basic introduction to fixed-effect and random-effects models for meta-analysis
Michael Borenstein et al.
RESEARCH SYNTHESIS METHODS (2010)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Advanced methods in meta-analysis: multivariate approach and meta-regression
HC van Houwelingen et al.
STATISTICS IN MEDICINE (2002)